Selected
Type of publications
Regions
Diseases
Vaccine topics
Target population
Publication date
815 results found
2024 ∙ NACI
Economic Evidence Supplementary Appendix to the Recommendations for Public Health Programs on the Use of Pneumococcal Vaccines in Children, Including the Use of 15-Valent and 20-Valent Conjugate Vaccines
  • Background paper
  • Canada
  • Pneumococcal disease
Download:
2024 ∙ NACI
Recommendations for public health programs on the use of pneumococcal vaccines in children, including the use of 15-valent and 20-valent conjugate vaccines
  • Recommendation
  • Canada
  • Pneumococcal disease
Download:
2023 ∙ Eiden, Amanda L. Barratt, Jane Nyaku, Mawuli K.
A review of factors influencing vaccination policies and programs for older adults globally
  • Adults
  • Older adults
  • Influenza
  • Pneumococcal disease
  • Herpes zoster
  • Tetanus
  • Acceptance
Rating:
Not applicable
2023 ∙ Tavabe, Nilay Rezaei Kheiri, Soleiman Dehghani, Mohsen Mohammadian-Hafshejani, Abdollah
A Systematic Review and Meta-Analysis of the Relationship between Receiving the Flu Vaccine with Acute Cerebrovascular Accident and Its Hospitalization in the Elderly
  • Older adults
  • Influenza
  • Efficacy/effectiveness
Rating:
Critically low
2023 ∙ Alsaif, F. Twigg, M. Scott, S. Blyth, A. Wright, D. Patel, A.
A systematic review of barriers and enablers associated with uptake of influenza vaccine among care home staff
  • Healthcare workers
  • Influenza
  • Acceptance
Rating:
Not applicable
2023 ∙ Jagne, Isatou von Mollendorf, Claire Wee-Hee, Ashleigh Ortika, Belinda Satzke, Catherine Russell, Fiona M.
A systematic review of pneumococcal conjugate vaccine impact on pneumococcal nasopharyngeal colonisation density in children under 5 years of age
  • Newborn
  • Children
  • Pneumococcal disease
  • Efficacy/effectiveness
Rating:
Low
2023 ∙ Doggen, Kris van Hoek, Albert Jan Luyten, Jeroen
Accounting for Adverse Events Following Immunization in Economic Evaluation: Systematic Review of Economic Evaluations of Pediatric Vaccines Against Pneumococcus, Rotavirus, Human Papillomavirus, Meningococcus and Measles-Mumps-Rubella-Varicella
  • Newborn
  • Children
  • Adolescents
  • Adults
  • Pneumococcal disease
  • Rotavirus
  • Human papillomavirus (HPV)
  • Meningococcal disease
  • Mumps
  • Measles
  • Rubella
  • Economic aspects
Rating:
Not applicable
2023 ∙ Pichichero, Michael Malley, Richard Kaur, Ravinder Zagursky, Robert Anderson, Porter
Acute otitis media pneumococcal disease burden and nasopharyngeal colonization in children due to serotypes included and not included in current and new pneumococcal conjugate vaccines
  • Children
  • Adolescents
  • Pneumococcal disease
  • Efficacy/effectiveness
  • Efficacy/effectiveness
Rating:
Critically low
2023 ∙ Bianchi, F. P. Stefanizzi, P. Di Lorenzo, A. De Waure, C. Boccia, S. Daleno, A. Migliore, G. Tafuri, S.
Attitudes toward influenza vaccination in healthcare workers in Italy: A systematic review and meta-analysis
  • Healthcare workers
  • Italy
  • Influenza
  • Acceptance
Rating:
Not applicable
2023 ∙ Nichol, Bethany McCready, Jemma Louise Steen, Mary Unsworth, John Simonetti, Valentina Tomietto, Marco
Barriers and facilitators of vaccine hesitancy for COVID-19, influenza, and pertussis during pregnancy and in mothers of infants under two years: An umbrella review
  • Vaccine/vaccination
  • Pregnant women
  • Parents/caregivers
  • COVID-19
  • Influenza
  • Pertussis
  • Acceptance
Rating:
Not applicable